Yayıncı "Churchill Livingstone" Tıp Fakültesi için listeleme
Toplam kayıt 6, listelenen: 1-6
-
Aminoguanidine mitigates apoptosis, testicular seminiferous tubules damage, and oxidative stress in streptozotocin-induced diabetic rats
(Churchill Livingstone, 2015)This study aimed to investigate the effect of aminoguanidine (AG) against testicular damage streptozotocin (STZ) induced diabetes. Thirty two rats were separated into four groups: control, AG, STZ and STZ + AG. In the STZ ... -
Ghrelin may reduce radiation-induced mucositis and anorexia in head-neck cancer
(Churchill Livingstone, 2007)Body weight toss is common in cancer patients, and is often associated with poor prognosis, it greatly impairs quality of life (QOL). Radiation therapy (RT) is used in head and neck cancers (HNC) either as a primary treatment ... -
Is a new perspective for definition and diagnostic criteria of fibromyalgia in early stage cancer patients necessary?
(Churchill Livingstone, 2014)Fibromyalgia is a most common pain syndrome characterized by the presence of chronic widespread pain and tenderness with manual palpation. However there is no enough data about frequent of fibromyalgia syndrome in patients ... -
Is there any effect of bolus and/or infusion 5-fluorouracil treatment on microalbuminuria in immediate or long term?
(Churchill Livingstone, 2014)5-Fluorouracil is a widely used cytotoxic chemotherapeutic agent in the treatment settings particularly in patients with gastrointestinal cancer. Various studies on the cardiac adverse effects of 5-fluorouracil, reported ... -
Other factors related to the completion of treatment after breast cancer
(Churchill Livingstone, 2015)Letter to the Editor -
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab
(Churchill Livingstone, 2016)Purpose: The aim of this study was to determine risk factors for brain metastasis as the first site of disease recurrence in patients with HER2-positive early-stage breast cancer (EBC) who received adjuvant trastuzumab. ...